A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).

[1]  S. Madhusudana,et al.  A comparative study on the immunogenicity, safety and tolerance of purified duck embryo vaccine (PDEV) manufactured in India (Vaxirab) and Switzerland (Lyssavac-N): a randomized simulated post-exposure study in healthy volunteers. , 2007, Vaccine.

[2]  F. Meslin,et al.  Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[3]  T. Lembo.  WHO Expert Consultation on rabies. , 2010, World Health Organization technical report series.

[4]  D. H. Narayana,et al.  Assessing the Relationship between Antigenecity and Immunogenecity of Human Rabies Vaccines: Results of a Meta-Analysis , 2005 .

[5]  P. Sonthon,et al.  Elimination of human rabies in a canine endemic province in Thailand: five-year programme. , 2003, Bulletin of the World Health Organization.

[6]  P. Khawplod,et al.  Economic issues in postexposure rabies treatment. , 1999, Journal of travel medicine.

[7]  T. Hulland.  A Biographical History of Veterinary Pathology , 1997 .

[8]  H. Koprowski,et al.  Laboratory Techniques in Rabies , 2022 .

[9]  P. Khawplod,et al.  Immunogenicity of purified duck embryo rabies vaccine (Lyssavac-N) with use of the WHO-approved intradermal postexposure regimen. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  R. Glück,et al.  Absence of myelin basic protein in an improved purified duck embryo rabies vaccine. , 1986, Neurochemical pathology.

[11]  R. Glück,et al.  [A highly efficient, highly purified duck embryo rabies vaccine]. , 1985, Schweizerische medizinische Wochenschrift.